美国大型队列显示C3肾小球肾炎与致密沉积物病病程相似
该研究回顾性分析了111例C3肾小球病患者的临床和病理数据,其中C3GN 87例、致密沉积物病24例,约35%为非白人。平均随访72个月,C3GN和致密沉积物病的缓解率分别为38%和25%,进展至晚期CKD或ESRD的比例分别为39%和42%,两者无差异。多变量模型显示诊断时eGFR和肾小管萎缩/间质纤维化是最强预测因素。
要点
- C3GN与致密沉积物病进展至晚期CKD/ESRD的比例相似(39% vs 42%)。
- 诊断时eGFR和肾小管萎缩/间质纤维化是进展的最强预测因素。
- C3肾小球病组织学指数中总活动性和总慢性化评分均为进展的强预测因素。
核心结论
- 在美国多样化C3肾小球病人群中,C3GN与致密沉积物病进展至CKD和ESRD的风险相似且均较高。
研究设计与样本
- 回顾性队列研究,纳入111例C3肾小球病患者(C3GN 87例,致密沉积物病24例),约35%为非白人,平均随访72个月。
主要发现
- C3GN缓解率38%,致密沉积物病缓解率25%。
- 进展至晚期CKD和ESRD:C3GN 39%,致密沉积物病42%,两者无差异。
- 筛查患者中补体相关基因变异检出率24%,自身抗体检出率35%。
- C3肾小球病组织学指数显示C3GN活动性更高,致密沉积物病慢性化更高。
关键数值与推荐
- 多变量模型中,临床变量模型最强预测因素为诊断时eGFR。
- 组织病理变量模型最强预测因素为肾小管萎缩/间质纤维化。
- C3肾小球病组织学指数中总活动性和总慢性化评分均为最强进展预测因素。
临床怎么用
- 对C3肾小球病患者应评估诊断时eGFR及肾小管萎缩/间质纤维化以分层进展风险。
- C3GN与致密沉积物病可采用相似的随访和监测策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
C3 glomerulonephritis (C3GN) and dense deposit disease comprise the two classes of C3 glomerulopathy. Studies from Europe and Asia have aided our understanding of this recently defined disorder, but whether these data apply to a diverse United States patient population remains unclear. We, therefore, reviewed clinical and histopathological data, including generation of a C3 Glomerulopathy Histologic Index to score biopsy activity and chronicity, to determine predictors of progression to end-stage renal disease (ESRD) and advanced chronic kidney disease (CKD) in 111 patients (approximately 35% non-white) with C3 glomerulopathy: 87 with C3GN and 24 with dense deposit disease. Complement-associated gene variants and autoantibodies were detected in 24% and 35% of screened patients, respectively. Our C3 Glomerulopathy Histologic Index denoted higher activity in patients with C3GN and higher chronicity in patients with dense deposit disease. Over an average of 72 months of follow-up, remission occurred in 38% of patients with C3GN and 25% of patients with dense deposit disease. Progression to late-stage CKD and ESRD was common, with no differences between C3GN (39%) and dense deposit disease (42%). In multivariable models, the strongest predictors for progression were estimated glomerular filtration rate at diagnosis (clinical variables model) and tubular atrophy/interstitial fibrosis (histopathology variables model). Using our C3 Glomerulopathy Histologic Index, both total activity and total chronicity scores emerged as the strongest predictors of progression. Thus, in a large, diverse American cohort of patients with C3 glomerulopathy, there is a high rate of progression to CKD and ESRD with no differences between C3GN and dense deposit disease.
引用
- Bomback AS, Santoriello D, Avasare RS, et al. C3 glomerulonephritis and dense deposit disease share a similar disease course in a large United States cohort of patients with C3 glomerulopathy. Kidney Int. 2018. PMID: 29310824. doi:10.1016/j.kint.2017.10.022
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。